97 results
Page 2 of 5
8-K
sepzb2c4odtehty8 mf
7 Sep 21
Adaptimmune Enters into a Strategic Collaboration with Genentech to Research, Develop, and Commercialize Cancer-targeted Allogeneic T-cell Therapies
7:08am
S-3ASR
EX-5.2
rdfkp1q6p3a
10 Aug 20
Automatic shelf registration
5:01pm
S-3ASR
EX-1.2
ysrybh id
10 Aug 20
Automatic shelf registration
5:01pm
8-K
EX-1.1
uosy5 kh9c
2 Jun 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
4:49pm
424B5
lj5t93n6xjkv
22 Jan 20
Prospectus supplement for primary offering
5:31pm
8-K
EX-1.1
kvdep381vgv
22 Jan 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
5:30pm
424B5
bhc8hdenmol7
21 Jan 20
Prospectus supplement for primary offering
5:21pm